Abstract:Tau has a wide variety of essential functions in the brain, but this protein also plays a determining role in the development of Alzheimer's disease (AD) and other neurodegenerative diseases called tauopathies. This is due to its abnormal aggregation and the subsequent formation of neurofibrillary tangles. Tau hyperphosphorylation appears to be a critical step in its transformation into an aggregated protein. However, the exact process, including the cellular events that trigger it, remains unclear. In this study, we employed immunocytochemistry assays on hippocampal sections from AD cases and from tauopathy cases (Braak stage III) with no evidence of cognitive decline, and the P301S mouse model to investigate the colocalization patterns of Tau phosphorylated (p) at specific residues (S202-T205, S214, and T231) within the proline-rich region. Our results show pyramidal neurons in the hippocampus of P301S mice in which Tau is intensely phosphorylated at residues S202 and T205 (recognized by the AT8 antibody), but with no detectable phosphorylation at S214 or T231. These non-colocalizing neurons displayed intensely labeled aggregated pTau deposits distributed through the soma and dendritic processes. However, most of the hippocampal pyramidal neurons are labeled with pTauS214 or pTauT231 antibodies and typically showed a homogeneous and diffuse pTau distribution (not aggregated). This different labeling likely reflects a Tau conformational step, potentially related to the transition from a diffuse tau phosphorylation phenotype (Type 2) into an NFT-like or Type 1 phenotype. We further observed that dendrites of CA3 pyramidal cells are intensely labeled with pTau214 in the stratum lucidum, but not with AT8 or pTauT231. By contrast, analysis of tissue from AD patients or other human tauopathy cases (Braak stage III) with no evidence of cognitive decline revealed extensive colocalization with both antibody combinations in CA1. The complete or mature tangle development may follow a different mechanism in the P301S mouse model or may require more time to achieve the maturity state found in AD cases. Further studies would be necessary to address this question.

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

GSK3 and p53 - is there a link in Alzheimer's disease?

Sting and p53 DNA repair pathways are compromised in Alzheimer's disease

Tau affects P53 function and cell fate during the DNA damage response

Hyperphosphorylation Results in Tau Dysfunction in DNA Folding and Protection.

Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.

p53 amyloid aggregation in cancer: function, mechanism, and therapy

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

Tdp-43 Interaction with the Intracellular Domain of Amyloid Precursor Protein Induces P53-Associated Apoptosis

Tau Ubiquitination in Alzheimer's Disease

Cofilin-Mediated Neuronal Apoptosis Via P53 Translocation and Pld1 Regulation

Conformation of P53 protein in peripheral lymphocytes from Alzheimer's disease patients

Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.

Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets

Role for Glyoxalase I in Alzheimer's Disease.

Targeting Misfolding and Aggregation of the Amyloid-β Peptide and Mutant p53 Protein using Multifunctional Molecules

Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes

Aβ induces PUMA activation: a new mechanism for Aβ-mediated neuronal apoptosis.

Super-Resolution Imaging Uncovers Nanoscale Tau Aggregate Hyperphosphorylation Patterns in Human Alzheimer’s Disease Brain Tissue

Overexpression Of Tau Proteins Antagonizes Amyloid-Beta-Potentiated Apoptosis Through Mitochondria-Caspase-3 Pathway In N2a Cells